Four New Projects Launch under Shared Development Infrastructure

News February 26, 2026

In the coming months, four new projects will get underway as part of the PharmaNL Shared Development Infrastructure (SDI) Call 2025, the second funding round within the PharmaNL SDI program line. The selected projects focus on building and/or upgrading infrastructure for the development, scale-up, and production of innovative medicines in the Netherlands. A total of 11 applications were submitted in this funding round.

The awarded four new projects are:

  • PHARMIGA: Infrastructure to accelerate the development of IgA-based medicines – Roos Masereeuw, Utrecht University

  • IMAGING4DRUGS: Integrated molecular imaging infrastructure for drug development – Rudolf Fehrmann, University Medical Center Groningen

  • RiboFlux: An all-in-one system for scalable, cGMP production of xRNA medicinal products – Sander van Asbeck, RIBROPRO B.V.

  • INFECTORY: Shared infrastructure for small-scale bacteriophage production – Meta Roestenberg, INFECTA

Over the next few months, these projects will be launched and showcased on the ZonMw website. Keep an eye on the PharmaNL webpage for updates.

About the Shared Development Infrastructure program line

The Shared Development Infrastructure (SDI) program, a collaboration between ZonMw and PharmaNL, allocates funds provided by the National Growth Fund (NGF) to expand and improve shared infrastructure for innovation in drug development and production in the Netherlands.

Funding projects within the SDI program can lead to more efficient and effective development of new medicines and production technologies, shorter lab-to-life timelines, and reduced costs for research groups and (start-up) companies. This investment also aims to strengthen the international position of the Dutch pharmaceutical sector.

Next funding round

ZonMw aims to open one more call within the PharmaNL SDI program line in 2026. More information on this funding round will be published on the ZonMw website in due course.

Source text and image: ZonMw